Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
3-Hydroxyisobutyryl-CoA hydrolase, encoded by HIBCH (HGNC:4908), is essential for valine catabolism. Biallelic pathogenic variants in HIBCH cause 3-Hydroxyisobutyryl-CoA hydrolase deficiency, a rare autosomal recessive metabolic disorder presenting as a Leigh-like syndrome with basal ganglia lesions, developmental delay, hypotonia, seizures, optic atrophy, dystonia, and ataxia. Brain MRI typically shows bilateral basal ganglia hyperintensities and progressive cerebral atrophy, and enzymatic studies frequently reveal multiple respiratory chain and pyruvate dehydrogenase deficiencies consistent with mitochondrial dysfunction.
To date, over 22 probands from more than 11 unrelated families have been reported, confirming autosomal recessive inheritance and segregation in both consanguineous and outbred pedigrees (PMID:34447000, PMID:25251209). A movement disorder series described 5 adolescent and adult patients from 2 unrelated families, expanding the phenotypic and age spectrum of the disease (PMID:27400804).
The variant spectrum includes frameshift (e.g., c.129dup (p.Gly44ArgfsTer20)), splice-site (c.664-2A>G, c.439-2A>G), and missense changes (c.287C>A (p.Ala96Asp)) affecting enzyme stability or activity (PMID:26163321, PMID:27896122). No clear genotype–phenotype correlations have been established beyond truncating variants tending toward more severe neonatal presentations (PMID:29703962).
Functional assays in patient fibroblasts demonstrate HIBCH activity below detectable limits in loss-of-function alleles, and transfection studies correlate residual activity with clinical severity, supporting a haploinsufficiency mechanism (PMID:27896122). Metabolite profiling consistently shows elevated hydroxy-C4-carnitine, and dietary intervention (low-valine diet) has yielded clinical and radiographic improvements in some cases (PMID:31679561).
Phenotypes range from fatal neonatal presentations with severe high-anion-gap metabolic acidosis and rapid neurodegeneration to childhood and adult-onset movement disorders dominated by dystonia and ataxia. Newborn screening for elevated hydroxy-C4-carnitine may facilitate early diagnosis and management (PMID:26026795).
Key Take-home: HIBCH deficiency is a strongly supported autosomal recessive disorder; early genetic testing combined with enzymatic assays enables diagnosis and guides dietary and supportive interventions.
Gene–Disease AssociationStrong22 probands across >11 unrelated families, autosomal recessive segregation, concordant functional data Genetic EvidenceStrongMultiple pathogenic variants including frameshift, splice-site, and missense alleles reported in >22 probands ([PMID:34447000]) Functional EvidenceModerateEnzyme assays in patient fibroblasts show undetectable activity; transfection studies correlate residual activity with severity ([PMID:27896122], [PMID:26163321]) |